Other mosquito-borne viral fevers

AB1_OTHER_MOSQUITO_FEVER

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A92, A93 Hospital discharge: ICD-9 — 06[6] Hospital discharge: ICD-8 — 06[7] Cause of death: ICD-10 — A92, A93 Cause of death: ICD-9 — 06[6] Cause of death: ICD-8 — 06[7] 2 out of 7 registries used, show all original rules.	77
4. Check minimum number of events None	77
5. Include endpoints None	77
6. Filter based on genotype QC (FinnGen only)	77

Control definitions (FinnGen only)

Control exclude: AB1_ARTHROPOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_OTHER_MOSQUITO_FEVER
CONTROL_EXCLUDE	AB1_ARTHROPOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A9[2-3]
HD_ICD_9	06[6]
HD_ICD_8	06[7]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A9[2-3]
COD_ICD_9	06[6]
COD_ICD_8	06[7]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other mosquito-borne viral fevers based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	699	362	335
Only index persons	635	339	296
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	46.07	48.04	43.79
Only index persons	45.47	47.71	42.91

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	77	42	35
Unadjusted period prevalence (%)	0.01	0.01	0.02
Median age at first event (years)	50.08	48.74	51.70

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
73: Matched controls
728

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A92.8

ICD-10 Finland

Other specified mosquito-borne viral fevers

+∞

55.4

A92.0

ICD-10 Finland

Chikungunya virus disease

+∞

7.4

M13.9

ICD-10 Finland

Arthritis, unspecified

8.7

7.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021788) Differential panel - Synovial fluid

10.70

3.56

1.3

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

6.87

3.26

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

143

2.24

2.61

3.7

5.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

5.32

2.45

1.0

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

4.24

2.08

2.3

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

139

2.06

2.07

1.4

1.7

1.31

1.25

mg/l

0.04

113

(40761535) Cells panel - Urine sediment

2.50

1.92

2.8

3.4

—

(3029937) Albumin [Presence] in Urine by Test strip

160

1.94

1.88

2.7

3.6

0.00

estimate

—

(3007164) IgA [Mass/volume] in Serum or Plasma

136

1.99

1.86

1.4

1.3

2.57

2.24

g/l

0.77

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3.52

1.78

2.3

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

4.03

1.74

1.0

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.33

1.69

2.3

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

3.33

1.69

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.97

1.69

1.3

1.2

0.18

0.23

g/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

245

1.79

1.67

3.2

3.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

312

1.76

1.62

4.6

4.9

0.00

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

312

1.76

1.62

3.1

3.5

0.00

estimate

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2.75

1.55

1.3

1.2

1.04

1.21

g/l

—

(3009261) Glucose [Presence] in Urine by Test strip

317

1.71

1.49

3.1

3.5

0.00

estimate

—

(3023368) Bacteria identified in Blood by Culture

163

1.79

1.48

3.1

4.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

139

1.82

1.44

1.5

2.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

116

1.85

1.38

1.2

8.06

43.04

iu/ml

—

(40761536) Microorganisms panel - Urine sediment

2.23

1.35

1.6

3.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.43

1.31

1.4

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

102

1.86

1.30

2.1

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2.51

1.27

1.5

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2.74

1.23

1.8

2.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

431

1.64

1.17

3.3

3.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.10

1.17

1.1

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2.60

1.17

1.8

2.2

11.50

10.66

mg/l

—

(3002256) Pathology report gross observation

1.91

1.15

1.4

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

183

1.64

1.15

2.5

3.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.83

1.14

1.1

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2.06

1.12

1.3

1.2

—

16.30

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

115

1.74

1.12

1.3

2.10

9.03

u/ml

—

(3015736) pH of Urine

248

1.58

1.11

3.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

150

1.65

1.09

1.4

1.3

0.85

1.92

u/ml

1.07

(1761868) Lipid panel - Serum or Plasma

240

1.57

1.08

2.1

2.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.02

1.07

3.3

3.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.16

1.06

1.7

2.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

101

1.74

1.04

2.5

3.6

12.90

93.15

ng/l

—

(3025941) Bacteria identified in Stool by Culture

1.98

0.97

1.0

1.2

—

(3018095) Leukocytes [#/volume] in Urine

219

1.52

0.93

2.5

3.2

8.53

58.08

e6/l

1.35

154

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.16

0.91

1.3

3.7

25.60

24.29

mmol/l

—

(3013512) EKG study

167

1.54

0.87

3.2

3.8

—

(3018010) Neutrophils/100 leukocytes in Blood

307

1.47

0.87

4.7

5.0

55.73

56.69

0.19

287

(4035726)

1.83

0.84

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.74

0.84

1.2

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.95

0.83

1.3

4.4

48.62

54.94

—

(42870588) Differential panel, method unspecified - Blood

199

1.46

0.76

7.2

5.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.92

0.76

1.9

2.5

63.66

66.70

g/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

654

1.77

0.75

12.5

14.3

139.91

139.78

mmol/l

0.23

640

(3020891) Body temperature

2.07

0.74

1.2

5.5

—

(3000492) Spirometry study

1.73

0.72

1.1

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

286

1.41

0.72

3.5

3.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

456

1.43

0.71

3.4

—

(3000330) Specific gravity of Urine by Test strip

1.91

0.70

2.2

6.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

139

1.49

0.69

3.4

3.3

—

(21494755) Public health laboratory ask at order entry panel

1.59

0.68

1.2

1.4

—

(36304419) Bacteria [Presence] in Urine

168

1.43

0.65

2.0

2.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

659

1.68

0.64

12.7

14.2

4.01

3.96

mmol/l

0.93

645

(3032080) INR in Blood by Coagulation assay

224

1.39

0.64

8.9

4.9

1.09

1.15

inr

0.25

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.62

0.63

1.1

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

225

1.38

0.62

2.5

3.7

22.24

37.17

ng/l

0.54

144

(40768797) Stomach Pathology biopsy report

1.57

0.61

1.9

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.61

0.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.61

0.0

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

402

1.36

0.60

3.2

3.8

—

20.33

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.72

0.58

1.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.63

0.56

1.2

2.4

1.40

1.62

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

220

1.35

0.54

2.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.58

0.54

1.3

3.2

125.67

128.33

g/l

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.54

0.54

1.3

2.3

21.82

22.76

0.09

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.46

0.54

1.7

2.1

278.78

384.25

nmol/l

—

(3044889) 12 lead EKG panel

437

1.33

0.53

2.2

3.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

130

1.39

0.49

2.4

2.7

0.63

0.71

ug/l

—

(40768804) Tissue Pathology biopsy report

262

1.31

0.48

2.2

2.0

—

(36660697) Celiac disease serology panel - Serum

1.47

0.47

1.0

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.45

0.45

1.8

2.2

13.28

12.87

umol/l

0.08

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.65

0.44

1.8

2.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1.60

0.43

1.0

3.7

1.50

1.33

mmol/l

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

334

1.27

0.43

3.7

6.9

9.46

10.24

umol/l

0.33

318

(1002224) Polysomnography panel

1.55

0.42

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

2.5

—

160.27

—

(40768793) Breast Pathology biopsy report

0.00

0.41

0.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.41

0.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.41

0.0

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.3

—

(3022621) pH of Urine by Test strip

1.50

0.41

1.6

2.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

2.3

—

0.40

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.41

0.0

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

0.41

0.0

2.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.44

0.41

1.5

2.3

2.47

2.34

g/l

0.27

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

110

0.70

0.41

1.5

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.40

0.0

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.41

0.40

1.2

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.46

0.40

2.2

2.8

—

(3000494) Fungus identified in Specimen by Culture

1.32

0.38

1.3

1.5

—

(40758558) Short blood count panel - Blood

174

1.28

0.37

5.6

6.9

—

(3022096) Basophils/100 leukocytes in Blood

291

1.23

0.34

6.5

5.2

0.68

0.61

0.40

267

(3003694) ABO and Rh group [Type] in Blood

166

1.28

0.34

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

639

1.37

0.34

14.3

13.6

23.37

24.29

mg/l

0.08

501

(3002032) Base excess in Venous blood by calculation

1.30

0.31

1.3

3.4

2.01

2.41

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.36

0.30

1.0

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

642

1.34

0.29

3.4

4.1

4.79

4.73

mmol/l

0.23

601

(3027945) Reticulocytes/100 erythrocytes in Blood

1.32

0.29

2.3

1.91

1.79

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.67

0.27

2.2

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.23

0.26

1.1

1.9

—

(3009542) Hematocrit [Volume Fraction] of Blood

607

0.82

0.24

12.6

13.0

40.69

40.04

0.25

488

(3012095) Magnesium [Moles/volume] in Serum or Plasma

0.76

0.24

1.6

3.8

0.82

0.81

mmol/l

—

(40761511) CBC panel - Blood by Automated count

677

1.37

0.24

12.5

11.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.34

0.24

1.6

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

360

1.17

0.23

3.6

4.4

6.22

6.67

mmol/l

1.19

335

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

111

0.79

0.22

1.8

3.2

2.51

2.45

mmol/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.6

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.0

—

64.20

—

(3024928) Oxygen saturation in Venous blood

0.00

0.21

0.0

2.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.26

0.20

1.5

2.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.20

0.0

1.9

—

6.64

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.20

0.0

1.4

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.20

0.0

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

639

1.23

0.19

3.6

4.1

1.44

1.46

mmol/l

0.15

590

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.25

0.18

1.5

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

168

1.17

0.18

3.5

4.1

16.06

22.69

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

694

1.30

0.16

14.7

14.6

74.66

76.50

umol/l

0.27

694

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

622

1.17

0.14

10.1

12.0

87.34

84.82

ml/min/173m2

0.55

504

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

597

0.88

0.12

4.3

5.5

38.62

39.68

mmol/mol

0.38

562

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

248

0.90

0.11

4.5

6.1

1.22

1.21

mmol/l

0.12

225

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.17

0.10

1.8

5.4

1.25

1.22

mmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

195

1.11

0.09

1.6

2.3

—

(3012544) pH of Venous blood

1.12

0.09

1.3

3.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

0.78

0.08

1.8

1.5

—

(3022145) Colonoscopy Study observation

1.12

0.08

1.3

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.03

0.08

2.6

7.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

141

0.91

0.06

1.7

2.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

241

1.06

0.03

1.4

1.8

86.23

90.23

pmol/l

0.19

130

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

658

0.92

0.03

3.8

4.5

3.00

2.82

mmol/l

1.06

614

(3019150) Specific gravity of Urine by Refractometry

143

1.06

0.01

4.5

3.5

1.02

kg/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

624

1.05

0.00

3.4

3.7

1.22

1.30

mmol/l

0.47

573

(3026008) Bacteria identified in Urine by Culture

172

0.99

0.00

2.2

2.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

135

0.96

0.00

1.1

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

115

1.05

0.00

1.5

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1.06

0.00

1.2

1.8

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.1

—

(3019225) pH of Specimen

0.92

0.00

5.4

4.9

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.0

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.4

—

26.50

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(4198724)

0.00

0.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

9.3

—

946.33

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.00

0.0

8.8

—

0.70

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.3

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

4.4

—

51.00

—

(3000991) Gas panel - Venous blood

1.02

0.00

5.2

7.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

4.2

—

4.02

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

3.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

4.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.3

—

(4268621)

0.00

0.0

2.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

0.0

2.1

—

11.26

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

2.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

12.7

—

1717.33

—

(3007461) Platelets [#/volume] in Blood

720

1.00

0.00

20.6

19.0

248.67

249.64

e9/l

0.04

704

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3024731) MCV [Entitic volume]

721

0.98

0.00

20.5

18.9

90.06

90.99

0.95

711

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

721

0.98

0.00

20.6

19.0

4.52

4.53

e12/l

0.08

701

(3012565) Volume of 24 hour Urine

0.00

0.0

1.8

—

1849.00

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.3

—

97.29

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

7.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

3.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

2.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.0

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3035941) MCH [Entitic mass]

721

0.98

0.00

20.4

18.9

29.93

30.34

1.21

711

(3000963) Hemoglobin [Mass/volume] in Blood

721

0.98

0.00

20.5

19.1

134.31

136.85

g/l

0.82

710

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

8.94

—

(4146454)

0.00

0.0

2.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

697

1.05

0.00

11.2

9.9

28.01

25.98

u/l

0.47

682

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_OTHER_MOSQUITO_FEVER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_OTHER_MOSQUITO_FEVER.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_MOSQUITO_FEVER – Other mosquito-borne viral fevers

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other mosquito-borne viral fevers

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints